Home Cart 0 Sign in  
X

[ CAS No. 822-36-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 822-36-6
Chemical Structure| 822-36-6
Chemical Structure| 822-36-6
Structure of 822-36-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 822-36-6 ]

Related Doc. of [ 822-36-6 ]

Alternatived Products of [ 822-36-6 ]

Product Details of [ 822-36-6 ]

CAS No. :822-36-6 MDL No. :MFCD00005201
Formula : C4H6N2 Boiling Point : -
Linear Structure Formula :- InChI Key :XLSZMDLNRCVEIJ-UHFFFAOYSA-N
M.W : 82.10 Pubchem ID :13195
Synonyms :

Calculated chemistry of [ 822-36-6 ]

Physicochemical Properties

Num. heavy atoms : 6
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.25
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 23.55
TPSA : 28.68 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.47 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.77
Log Po/w (XLOGP3) : 0.46
Log Po/w (WLOGP) : 0.72
Log Po/w (MLOGP) : -0.47
Log Po/w (SILICOS-IT) : 1.56
Consensus Log Po/w : 0.61

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.26
Solubility : 4.56 mg/ml ; 0.0555 mol/l
Class : Very soluble
Log S (Ali) : -0.63
Solubility : 19.2 mg/ml ; 0.234 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.51
Solubility : 2.55 mg/ml ; 0.0311 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 822-36-6 ]

Signal Word:Danger Class:8
Precautionary Statements:P501-P260-P270-P202-P201-P264-P280-P308+P313-P303+P361+P353-P301+P330+P331-P363-P301+P312+P330-P304+P340+P310-P305+P351+P338+P310-P405 UN#:3263
Hazard Statements:H302-H314-H351 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 822-36-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 822-36-6 ]
  • Downstream synthetic route of [ 822-36-6 ]

[ 822-36-6 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 6014-42-2 ]
  • [ 822-36-6 ]
  • [ 930-62-1 ]
Reference: [1] Chemische Berichte, 1907, vol. 40, p. 801
  • 2
  • [ 822-36-6 ]
  • [ 219814-29-6 ]
YieldReaction ConditionsOperation in experiment
99% With N-Bromosuccinimide In tetrahydrofuran at 20℃; for 1 h; [0229] To a solution of 3-1 (3.4 g, 40 mmol) in THF (50 mL) at r.t. was added NBS ( 14 g, 80 mmol). The mixture was stirred for 1 h. The solvent were removed under reduced pressure. Purification by column chromatography on silica gel (PE:EA=2: 1 ) provided 3-2 as white solid (9.6 g, 99percent). +E SI-MS: m/z 239.0 [M+H]+
Reference: [1] Patent: WO2015/26792, 2015, A1, . Location in patent: Paragraph 0229
  • 3
  • [ 822-36-6 ]
  • [ 14003-66-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 3, p. 427 - 440
[2] Chemische Berichte, 1909, vol. 42, p. 761
[3] Journal of the Chemical Society, 1942, p. 232,233
[4] Patent: US4678799, 1987, A,
  • 4
  • [ 116-09-6 ]
  • [ 1739-84-0 ]
  • [ 822-36-6 ]
Reference: [1] Patent: US2017/240515, 2017, A1, . Location in patent: Paragraph 0064-0067
  • 5
  • [ 116-09-6 ]
  • [ 1739-84-0 ]
  • [ 59502-84-0 ]
  • [ 822-36-6 ]
Reference: [1] Patent: US2017/240515, 2017, A1, . Location in patent: Paragraph 0064-0067
  • 6
  • [ 822-36-6 ]
  • [ 67-66-3 ]
  • [ 38557-71-0 ]
  • [ 3435-25-4 ]
  • [ 59303-10-5 ]
  • [ 54198-82-2 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1427 - 1430
  • 7
  • [ 822-36-6 ]
  • [ 67-66-3 ]
  • [ 38557-71-0 ]
  • [ 3435-25-4 ]
  • [ 59303-10-5 ]
  • [ 54198-82-2 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1427 - 1430
  • 8
  • [ 822-36-6 ]
  • [ 67-66-3 ]
  • [ 38557-71-0 ]
  • [ 3435-25-4 ]
  • [ 59303-10-5 ]
  • [ 54198-82-2 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1427 - 1430
  • 9
  • [ 822-36-6 ]
  • [ 3034-50-2 ]
Reference: [1] Patent: CN107954938, 2018, A, . Location in patent: Paragraph 0021; 0028; 0035; 0042; 0049
  • 10
  • [ 822-36-6 ]
  • [ 1072-84-0 ]
Reference: [1] Patent: CN106349166, 2017, A, . Location in patent: Paragraph 0018-0029
  • 11
  • [ 822-36-6 ]
  • [ 15813-07-7 ]
Reference: [1] Patent: WO2017/74832, 2017, A1, . Location in patent: Page/Page column 42
  • 12
  • [ 822-36-6 ]
  • [ 73746-43-7 ]
Reference: [1] Journal of Organic Chemistry, 1980, vol. 45, # 15, p. 3108 - 3111
[2] Journal of Organic Chemistry, 1980, vol. 45, # 15, p. 3108 - 3111
  • 13
  • [ 822-36-6 ]
  • [ 328-67-6 ]
  • [ 641571-13-3 ]
YieldReaction ConditionsOperation in experiment
65% With trans-N,N'-dimethyl-1,2-cyclohexyldiamine; potassium phosphate; copper(l) iodide In 1,4-dioxane at 115℃; for 72 h; Molecular sieve Coupling reaction: A reaction flask was charged with 3-bromo-5-trifluoromethylbenzoic acid (compound 2, 2.7 g, 0.01 mol), 4-methyl-1H- imidazole (1.64 g, 1), trans- N, N'-dimethylcyclohexanediamine (0.28 g, 0.002 mol), 1,4-dioxane (10 vol./g), anhydrous potassium phosphate , 0.03mol) and 4A molecular sieves (0. lg / g), to form a mixed system; the mixed system is purged with nitrogen to have an oxygen content of 500ppm, finally adding cuprous iodide (0.38g, 0.002mol) The system was heated to 115 ° C, the reaction was stirred for 72 hours, TLC showed compound 2 disappeared to give the product system; and then the system was cooled to room temperature, transferred to 2M hydrochloric acid quenched, concentrated filtered without fraction To be purified solution. Adding n-butanol, extracting and separating the organic phase, extracting with n-butanol twice, and combining the organic phases; concentrating the organic phase to remove n-butanol to obtain 3- (4-methyl- -5- (trifluoromethyl) benzoic acid (Compound 3) crude. Recrystallization from methanol (4: 1 ./g) gave 1.76 g of a khaki-colored solid in 65percent yield.
Reference: [1] Patent: CN104592122, 2018, B, . Location in patent: Paragraph 0102- 0103
  • 14
  • [ 822-36-6 ]
  • [ 128495-46-5 ]
  • [ 870837-18-6 ]
YieldReaction ConditionsOperation in experiment
15% With caesium carbonate In N,N-dimethyl-formamide at 100℃; for 1 h; Inert atmosphere 4-Fluoro-3-methoxybenzaldehyde (85 g, 0.55 mol), 4-methyl-1 /-/-imidazole (90.5 g,1.1 mol) and cesium carbonate (268.8 g, 0.82 mol) were combined in dimethylformamide (1.7 L) and stirred at 100 0C for 1 hour. The mixture was cooled to room temperature, filtered, and the filtrate was concentrated in vacuo. The residue was dissolved in water (2 L) and extracted with ethyl acetate (3 x 2 L). The combined organic layers were washed with water and brine, dried over sodium sulfate, and concentrated under reduced pressure. Chromatography on silica (Eluant: 2:1 petroleum ether: ethyl acetate) afforded a yellow solid, which was recrystallized from ethyl acetate (300 mL) to provide the title compound as a white solid. Yield: 17.8 g, 0.082 mol, 15percent. 1H NMR (300 MHz, CDCI3) δ 2.31 (d, J=1.0 Hz, 3H), 3.97 (s, 3H), 7.01 (m, 1H), 7.45 (d, J=7.8 Hz, 1 H), 7.54-7.58 (m, 2H), 7.83 (d, J=1.3 Hz, 1 H), 10.01 (s, 1 H).
Reference: [1] Patent: WO2010/100606, 2010, A1, . Location in patent: Page/Page column 41-42
[2] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 2, p. 773 - 776
[3] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 13, p. 4083 - 4087
[4] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 9, p. 3140 - 3146
[5] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 9, p. 3140 - 3146
[6] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 21, p. 6523 - 6532,10
[7] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 21, p. 6523 - 6532
[8] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 19, p. 4630 - 4637
[9] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 17, p. 3488 - 3494
  • 15
  • [ 822-36-6 ]
  • [ 128495-46-5 ]
  • [ 870837-18-6 ]
  • [ 870837-19-7 ]
Reference: [1] Patent: EP1953151, 2008, A1, . Location in patent: Page/Page column 14
[2] Patent: US2006/241038, 2006, A1, . Location in patent: Page/Page column 29
[3] Patent: WO2008/156580, 2008, A1, . Location in patent: Page/Page column 29-30
[4] Patent: US2006/4013, 2006, A1, . Location in patent: Page/Page column 49
  • 16
  • [ 243128-37-2 ]
  • [ 822-36-6 ]
  • [ 1243204-92-3 ]
YieldReaction ConditionsOperation in experiment
53% With caesium carbonate In N,N-dimethyl-formamide at 20℃; for 96 h; Inert atmosphere 4-Methylimidazole (249 mg, 3.03 mmol), 4-fluoro-3-methoxybenzonitrile (417 mg, 2.76 mmol), and cesium carbonate (1.89 g, 5.80 mmol) were placed in a reaction vessel in a nitrogen gas atmosphere, N,N-dimethylformamide (5.0 mL) was added to the vessel and the resultant mixture was stirred at room temperature for 96 hours. To the reaction mixture were successively added water (2 mL) and ethyl acetate (6 mL) to perform an extraction, and the aqueous layer was separated and then, the organic layer was washed with water (5 mL). To the organic layer were added ethyl acetate (5 mL) and water (5 mL) to perform an extraction, and the aqueous layer was separated and then, the organic layer was washed with water (5 mL) and concentrated under a reduced pressure to obtain 499 mg of a crude product. To the crude product was added tert-butyl methyl ether (2.5 mL) to obtain a suspension, and the solids collected by filtration of the suspension were washed with tert-butyl methyl ether/heptane (2.5 ml; 1 :3) three times to obtain 431 mg of a crude product. To the obtained crude product was added tert-butyl methyl ether (4.3 mL) in a nitrogen gas atmosphere, and the resultant mixture was stirred at 50°C for 30 minutes and then naturally cooled to room temperature, and the solids collected by filtration were washed with tert-butyl methyl ether/heptane (2.1 mL; 1 :3) twice and dried under a reduced pressure to obtain 310 mg of a title compound. Yield: 53percent.
49.9% With potassium carbonate In dimethyl sulfoxide at 120℃; for 1 h; Example Al a) Preparation of intermediate 1. K2CO3 (112 g, 0.81 mol) was added to a stirred sol. of 4-methylimidazole (66.0 g, 0.804 mol) in DMSO (600 ml). The r.m. was heated at 120 0C. Subsequently 4-fluoro- 3-methoxybenzonitrile (60.0 g, 0.397 mol) was added portionwise (internal reaction temperature increased to 140 0C). The r.m. was maintained at 120 0C for 1 h, was cooled, and was then poured onto ice-water (3 1). This mixture was stirred for 30 min. The precipitated solid was collected by filtration and washed with H2O. The off-white solid was recrystallised from MeCN to yield 30.0 g of intermediate 1. A second crop of product was obtained from the mother liquor. Yield: 12.3 g of intermediate 1(combined yield; 49.9 percent).
39% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 135 - 140 h; Inert atmosphere 4-Fluoro-3-methoxybenzonitrile (98.2 g, 0.65 mol) was combined with 4-methyl-1 /-/- imidazole (53.4 g, 0.65 mol) and anhydrous potassium carbonate (138.2 g, 1 mol, 1.54 eq) in dimethylformamide (650 ml_), and the reaction mixture was stirred for 16 hours at 135-140 0C (internal temperature). The mixture was cooled to room temperature and filtered; the salts were washed with dichloromethane (3 x 30 ml_). The combined filtrates were evaporated in vacuo to afford a brown semisolid, which was suspended in water (500 ml_) and left to stand at 5 0C for 24 hours. The mixture was filtered, and the solid was washed with ice water (2 x 50 ml_), then dried in vacuo to afford a yellow solid (105.5 g). Crystallization from methanol (106 ml_) provided purified product (66.3 g) as yellowish crystals. These were boiled with acetone (100 ml_) for 5 minutes and the mixture was left to cool overnight. The mixture was filtered, and the crystals were washed with acetone (2 x 10 ml_) to afford the title compound as a white solid. Yield: 54.6 g, 0.256 mmol, 39percent. 1H NMR (400 MHz, CDCI3) δ 2.31 (d, J=1.0 Hz, 3H), 3.94 (s, 3H), 6.97 (m, 1 H), 7.30 (m, 1 H), 7.37 (m, 2H), 7.79 (d, J=1.4 Hz, 1 H).
Reference: [1] Patent: WO2011/37244, 2011, A1, . Location in patent: Page/Page column 12; 13
[2] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 17, p. 4794 - 4800
[3] Patent: WO2011/6903, 2011, A1, . Location in patent: Page/Page column 116
[4] Patent: WO2010/100606, 2010, A1, . Location in patent: Page/Page column 38-39
[5] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 8, p. 2906 - 2911
[6] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 13, p. 4083 - 4087
[7] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 24, p. 5805 - 5813
  • 17
  • [ 822-36-6 ]
  • [ 1241428-31-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 24, p. 5805 - 5813
Same Skeleton Products
Historical Records

Related Parent Nucleus of
[ 822-36-6 ]

Imidazoles

Chemical Structure| 53316-51-1

[ 53316-51-1 ]

4,5-Dimethyl-1H-imidazole hydrochloride

Similarity: 0.83

Chemical Structure| 66247-84-5

[ 66247-84-5 ]

(1H-Imidazol-4-yl)methanamine hydrochloride

Similarity: 0.83

Chemical Structure| 38585-61-4

[ 38585-61-4 ]

4-(Chloromethyl)-1H-imidazole hydrochloride

Similarity: 0.81

Chemical Structure| 57090-88-7

[ 57090-88-7 ]

1H-Imidazole-4-carbonitrile

Similarity: 0.81

Chemical Structure| 822-55-9

[ 822-55-9 ]

4-(Hydroxymethyl)imidazole

Similarity: 0.79